posted on Dec 31 by MedPage Today OB/Gyn in the Uncategorized category
A massive new database-driven study of effects of prescription drugs during pregnancy, called the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP), is getting under way under FDA sponsorship, the agency announced.